UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 422

Sortiert nach

Overproduction of large VLDL particles is driven by increased liver fat content in man

Diabetologia, 2006-04, Vol.49 (4), p.755-765

2006

Volltextzugriff (PDF)

The PROactive study: some answers, many questions

The Lancet (British edition), 2005-10, Vol.366 (9493), p.1241-1242

Yki-Järvinen, Hannele

2005

Volltextzugriff (PDF)

Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly

Diabetologia, 2012-04, Vol.55 (4), p.1186-1194

2012

Volltextzugriff (PDF)

Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month extension

Diabetes, obesity & metabolism, 2015-12, Vol.17 (12), p.1142-1149

2015

Volltextzugriff (PDF)

Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes

Diabetes, obesity & metabolism, 2015-09, Vol.17 (9), p.859-867

2015

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease and risk of type 2 diabetes

Best Practice & Research Clinical Endocrinology & Metabolism, 2016-06, Vol.30 (3), p.385-395

2016

Volltextzugriff (PDF)

One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension

Diabetes, obesity & metabolism, 2015-09, Vol.17 (9), p.835-842

2015

Volltextzugriff (PDF)

Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2010-02, Vol.12 (2), p.167-177

2010

Volltextzugriff (PDF)

common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans

Diabetologia, 2009-06, Vol.52 (6), p.1056-1060

2009

Volltextzugriff (PDF)

Comparison of insulin glargine and liraglutide added to oral agents in patients with poorly controlled type 2 diabetes

Diabetes, obesity & metabolism, 2015-02, Vol.17 (2), p.170-178

2015

Volltextzugriff (PDF)

Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations

Diabetologia, 2009-04, Vol.52 (4), p.684-690

2009

Volltextzugriff (PDF)

Inaccuracies in food and physical activity diaries of obese subjects: complementary evidence from doubly labeled water and co-twin assessments

International Journal of Obesity, 2010-03, Vol.34 (3), p.437-445

2010

Volltextzugriff (PDF)

Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2011-04, Vol.13 (4), p.374-377

2011

Volltextzugriff (PDF)

Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study

Diabetologia, 2006-03, Vol.49 (3), p.442-451

2006

Volltextzugriff (PDF)

Gene expression profile of subcutaneous adipose tissue in BMI-discordant monozygotic twin pairs unravels molecular and clinical changes associated with sub-types of obesity

International Journal of Obesity, 2017-08, Vol.41 (8), p.1176-1184

2017

Volltextzugriff (PDF)

Efficacy and safety of linagliptin as add-on therapy to basal insulin and metformin in people with Type 2 diabetes

Diabetic medicine, 2016-07, Vol.33 (7), p.926-933

2016

Volltextzugriff (PDF)

Type 2 diabetes: remission in just a week

Diabetologia, 2011-10, Vol.54 (10), p.2477-2479

Yki-Järvinen, H.

2011

Volltextzugriff (PDF)

Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women

Circulation (New York, N.Y.), 2000-11, Vol.102 (22), p.2687-2693

2000

Volltextzugriff (PDF)

A desktop guide to Type 2 diabetes mellitus

Diabetic medicine, 1999-09, Vol.16 (9), p.716-730

European Diabetes Policy Group, 1999

1999

Volltextzugriff (PDF)

Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trial

Diabetes research and clinical practice, 2019-07, Vol.153, p.14-22

2019

Volltextzugriff (PDF)

DRUG THERAPY: Thiazolidinediones

The New England journal of medicine, 2004-09, Vol.351 (11), p.1106

Yki-Järvinen, Hannele

2004

Volltextzugriff (PDF)

Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy

Arteriosclerosis, thrombosis, and vascular biology, 2003-04, Vol.23 (4), p.688

2003

Volltextzugriff (PDF)

The fatty liver and insulin resistance

Current molecular medicine, 2005-05, Vol.5 (3), p.287

2005

Volltextzugriff (PDF)

Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity

Diabetes care, 2000-03, Vol.23 (3), p.295-301

2000

Volltextzugriff (PDF)

One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients: A randomized, controlled trial

Diabetes care, 2009-05, Vol.32 (5), p.762-768

2009

Volltextzugriff (PDF)

1 – 25 von 422

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(390)
Mit Volltextzugriff
(349)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(304)
Science & Technology
(271)
Life Sciences & Biomedicine
(269)
Biological And Medical Sciences
(228)
Male
(227)
Adult
(190)
Medical Sciences
(184)
Endocrinology & Metabolism
(167)
Female
(164)
Middle Aged
(136)
Endocrinopathies
(105)
Insulin Resistance
(101)
Endocrine Pancreas. Apud Cells
(95)
Diabetes. Impaired Glucose Tolerance
(90)
Insulin - Blood
(87)
Insulin
(79)
Blood Glucose - Metabolism
(77)
Etiopathogenesis. Screening. Investigations. Target Tissue Resistance
(69)
Glucose - Metabolism
(69)
Insulin - Pharmacology
(69)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Overproduction of large VLDL particles is driven by increased liver fat content in man

The PROactive study: some answers, many questions

Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly

Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month extension

Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes

Non-alcoholic fatty liver disease and risk of type 2 diabetes

One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension

Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes

common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans

Comparison of insulin glargine and liraglutide added to oral agents in patients with poorly controlled type 2 diabetes

Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations

Inaccuracies in food and physical activity diaries of obese subjects: complementary evidence from doubly labeled water and co-twin assessments

Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes

Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study

Gene expression profile of subcutaneous adipose tissue in BMI-discordant monozygotic twin pairs unravels molecular and clinical changes associated with sub-types of obesity

Efficacy and safety of linagliptin as add-on therapy to basal insulin and metformin in people with Type 2 diabetes

Type 2 diabetes: remission in just a week

Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women

A desktop guide to Type 2 diabetes mellitus

Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trial

DRUG THERAPY: Thiazolidinediones

Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy

The fatty liver and insulin resistance

Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity

One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients: A randomized, controlled trial

Suchergebnisse filtern